Molecular mechanisms of host cell invasion by Trypanosoma cruzi

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 283-291

  Epting, Conrad L ^a   Coates, Bria M ^a   Engman, David M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Invasion; Lysosome; Microtubules; Signaling; Trypanosoma cruzi

Indexed keywords

BRADYKININ B2 RECEPTOR; CYCLIC AMP; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; CALCIUM; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; PROTOZOAL PROTEIN;

AMASTIGOTE; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL INVASION; CELL SURFACE; CELL VACUOLE; CHAGAS DISEASE; CYTOSKELETON; ENDOSOME; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYSOSOME; MEMBRANE BINDING; NONHUMAN; PARASITE VIRULENCE; PHAGOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; ANIMAL; CELL MEMBRANE; CYTOPLASM; DISEASE CARRIER; EXTRACELLULAR MATRIX; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM; CELL MEMBRANE; CHAGAS DISEASE; CYTOPLASM; CYTOSKELETON; EXTRACELLULAR MATRIX; HOST-PARASITE INTERACTIONS; HUMANS; INSECT VECTORS; MEMBRANE GLYCOPROTEINS; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI;

PROTOZOA; TRYPANOSOMA CRUZI;

EID: 77956260301     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.06.023     Document Type: Article

References (158)

1. Alves M.J., Colli W. Trypanosoma cruzi: adhesion to the host cell and intracellular survival. IUBMB Life 2007, 59:274-279.
2. Alves M.J., Colli W. Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of Trypanosoma cruzi with host structures. Subcell. Biochem. 2008, 47:58-69.
3. Andrade L.O., Andrews N.W. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J. Exp. Med. 2004, 200:1135-1143.
4. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 2005, 3:819-823.
5. Andrade L.O., Machado C.R., Chiari E., Pena S.D., Macedo A.M. Differential tissue distribution of diverse clones of Trypanosoma cruzi in infected mice. Mol. Biochem. Parasitol. 1999, 100:163-172.
6. Andrews N.W. From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi. Braz. J. Med. Biol. Res. 1994, 27:471-475.
7. Andrews N.W. Lysosome recruitment during host cell invasion by Trypanosoma cruzi. Trends Cell Biol. 1995, 5:133-137.
8. Andrews N.W., Abrams C.K., Slatin S.L., Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell 1990, 61:1277-1287.
9. Barrias E.S., Dutra J.M., De Souza W., Carvalho T.M. Participation of macrophage membrane rafts in Trypanosoma cruzi invasion process. Biochem. Biophys. Res. Commun. 2007, 363:828-834.
10. Barrias E.S., Reignault L.C., De Souza W., Carvalho T.M. Dynasore, a dynamin inhibitor, inhibits Trypanosoma cruzi entry into peritoneal macrophages. PLoS One 2010, 5:e7764.
11. Bartholomeu D.C., Ropert C., Melo M.B., Parroche P., Junqueira C.F., Teixeira S.M., Sirois C., Kasperkovitz P., Knetter C.F., Lien E., Latz E., Golenbock D.T., Gazzinelli R.T. Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J. Immunol. 2008, 181:1333-1344.
12. Bogdan C., Rollinghoff M. How do protozoan parasites survive inside macrophages?. Parasitol. Today 1999, 15:22-28.
13. Brown D., Waneck G.L. Glycosyl-phosphatidylinositol-anchored membrane proteins. J. Am. Soc. Nephrol. 1992, 3:895-906.
14. Burleigh, B.A., 2005. Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes? Sci. STKE pe36.
15. Burleigh B.A., Andrews N.W. Signaling and host cell invasion by Trypanosoma cruzi. Curr. Opin. Microbiol. 1998, 1:461-465.
16. 2+ signaling in mammalian cells. J. Cell Biol. 1997, 136:609-620.
17. Caler E.V., Vaena de Avalos S., Haynes P.A., Andrews N.W., Burleigh B.A. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 1998, 17:4975-4986.
18. Caler E.V., Chakrabarti S., Fowler K.T., Rao S., Andrews N.W. The Exocytosis-regulatory protein synaptotagmin VII mediates cell invasion by Trypanosoma cruzi. J. Exp. Med. 2001, 193:1097-1104.
19. Campos M.A., Gazzinelli R.T. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors. Mediat. Inflamm. 2004, 13:139-143.
20. Chessler A.D., Ferreira L.R., Chang T.H., Fitzgerald K.A., Burleigh B.A. A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts. J. Immunol. 2008, 181:7917-7924.
21. Chessler A.D., Unnikrishnan M., Bei A.K., Daily J.P., Burleigh B.A. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. J. Immunol. 2009, 182:2288-2296.
22. Clark R.K., Kuhn R.E. Trypanosoma cruzi does not induce apoptosis in murine fibroblasts. Parasitology 1999, 118(Pt 2):167-175.
23. Coimbra V.C., Yamamoto D., Khusal K.G., Atayde V.D., Fernandes M.C., Mortara R.A., Yoshida N., Alves M.J., Rabinovitch M. Enucleated L929 cells support invasion, differentiation, and multiplication of Trypanosoma cruzi parasites. Infect. Immun. 2007, 75:3700-3706.
24. Colli W. Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J. 1993, 7:1257-1264.
25. Cortez M., Neira I., Ferreira D., Luquetti A.O., Rassi A., Atayde V.D., Yoshida N. Infection by Trypanosoma cruzi metacyclic forms deficient in gp82 but expressing a related surface molecule, gp30. Infect. Immun. 2003, 71:6184-6191.
26. Coura J.R. Chagas disease: what is known and what is needed - a background article. Mem. Inst. Oswaldo Cruz 2007, 102(Suppl. 1):113-122.
27. Coura J.R., Dias J.C. Epidemiology, control and surveillance of Chagas disease - 100years after its discovery. Mem. Inst. Oswaldo Cruz 2009, 104:31-40.
28. Daniels M.D., Hyland K.V., Engman D.M. Treatment of experimental myocarditis via modulation of the renin-angiotensin system. Curr. Pharm. Des. 2007, 13:1299-1305.
29. De Araujo-Jorge T.C., Barbosa H.S., Meirelles M.N. Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study. Mem. Inst. Oswaldo Cruz 1992, 87(Suppl. 5):43-56.
30. de Carvalho T.M., de Souza W. Early events related with the behaviour of Trypanosoma cruzi within an endocytic vacuole in mouse peritoneal macrophages. Cell Struct. Funct. 1989, 14:383-392.
31. De Souza W. Basic cell biology of Trypanosoma cruzi. Curr. Pharm. Des. 2002, 8:269-285.
32. de Titto E.H., Araujo F.G. Mechanism of cell invasion by Trypanosoma cruzi: importance of sialidase activity. Acta Trop. 1987, 44:273-282.
33. Denny P.W., Field M.C., Smith D.F. GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida. FEBS Lett. 2001, 491:148-153.
34. Dias W.B., Fajardo F.D., Graca-Souza A.V., Freire-de-Lima L., Vieira F., Girard M.F., Bouteille B., Previato J.O., Mendonca-Previato L., Todeschini A.R. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi. Cell. Microbiol. 2008, 10:88-99.
35. Dorta M.L., Ferreira A.T., Oshiro M.E., Yoshida N. Ca2+ signal induced by Trypanosoma cruzi metacyclic trypomastigote surface molecules implicated in mammalian cell invasion. Mol. Biochem. Parasitol. 1995, 73:285-289.
36. DosReis G.A., Pecanha L.M., Bellio M., Previato J.O., Mendonca-Previato L. Glycoinositol phospholipids from Trypanosoma cruzi transmit signals to the cells of the host immune system through both ceramide and glycan chains. Microbes Infect. 2002, 4:1007-1013.
37. Dvorak J.A., Hyde T.P. Trypanosoma cruzi: interaction with vertebrate cells in vitro. I. Individual interactions at the cellular and subcellular levels. Exp. Parasitol. 1973, 34:268-283.
38. Elias M.C., Marques-Porto R., Freymuller E., Schenkman S. Transcription rate modulation through the Trypanosoma cruzi life cycle occurs in parallel with changes in nuclear organisation. Mol. Biochem. Parasitol. 2001, 112:79-90.
39. El-Sayed N.M., Myler P.J., Bartholomeu D.C., Nilsson D., Aggarwal G., Tran A.N., Ghedin E., Worthey E.A., Delcher A.L., Blandin G., Westenberger S.J., Caler E., Cerqueira G.C., Branche C., Haas B., Anupama A., Arner E., Aslund L., Attipoe P., Bontempi E., Bringaud F., Burton P., Cadag E., Campbell D.A., Carrington M., Crabtree J., Darban H., da Silveira J.F., de Jong P., Edwards K., Englund P.T., Fazelina G., Feldblyum T., Ferella M., Frasch A.C., Gull K., Horn D., Hou L., Huang Y., Kindlund E., Klingbeil M., Kluge S., Koo H., Lacerda D., Levin M.J., Lorenzi H., Louie T., Machado C.R., McCulloch R., McKenna A., Mizuno Y., Mottram J.C., Nelson S., Ochaya S., Osoegawa K., Pai G., Parsons M., Pentony M., Pettersson U., Pop M., Ramirez J.L., Rinta J., Robertson L., Salzberg S.L., Sanchez D.O., Seyler A., Sharma R., Shetty J., Simpson A.J., Sisk E., Tammi M.T., Tarleton R., Teixeira S., Van Aken S., Vogt C., Ward P.N., Wickstead B., Wortman J., White O., Fraser C.M., Stuart K.D., Andersson B. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309:409-415.
40. Factor S.M., Cho S., Wittner M., Tanowitz H. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 1985, 34:246-253.
41. Favoreto S., Dorta M.L., Yoshida N. Trypanosoma cruzi 175-kDa protein tyrosine phosphorylation is associated with host cell invasion. Exp. Parasitol. 1998, 89:188-194.
42. Ferguson M.A., Cross G.M.A. Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J. Biol. Chem. 1984, 259:3011-3015.
43. Ferguson M.A., Brimacombe J.S., Cottaz S., Field R.A., Guther L.S., Homans S.W., McConville M.J., Mehlert A., Milne K.G., Ralton J.E., et al. Glycosyl-phosphatidylinositol molecules of the parasite and the host. Parasitology 1994, 108(Suppl.):S45-S54.
44. Fernandes A.B., Mortara R.A. Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages. Microbes Infect. 2004, 6:460-467.
45. Fernandes A.B., Neira I., Ferreira A.T., Mortara R.A. Cell invasion by Trypanosoma cruzi amastigotes of distinct infectivities: studies on signaling pathways. Parasitol. Res. 2006, 100:59-68.
46. Fernandes M.C., Cortez M., Geraldo Yoneyama K.A., Straus A.H., Yoshida N., Mortara R.A. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Int. J. Parasitol. 2007, 37:1431-1441.
47. Fernandez M.A., Munoz-Fernandez M.A., Fresno M. Involvement of beta 1 integrins in the binding and entry of Trypanosoma cruzi into human macrophages. Eur. J. Immunol. 1993, 23:552-557.
48. Field M.C., Medina-Acosta E., Cross G.A. Characterization of a glycosylphosphatidylinositol membrane protein anchor precursor in Leishmania mexicana. Mol. Biochem. Parasitol. 1991, 48:227-229.
49. Florencio-Martinez L., Marquez-Duenas C., Ballesteros-Rodea G., Martinez-Calvillo S., Manning-Cela R. Cellular analysis of host cell infection by different developmental stages of Trypanosoma cruzi. Exp. Parasitol. 2010, 126:332-336.
50. Freitas J.M., Andrade L.O., Pires S.F., Lima R., Chiari E., Santos R.R., Soares M., Machado C.R., Franco G.R., Pena S.D., Macedo A.M. The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains. PLoS One 2009, 4:e5113.
51. Fujita M., Jigami Y. Lipid remodeling of GPI-anchored proteins and its function. Biochim. Biophys. Acta 2008, 1780:410-420.
52. Gaulton G.N., Pratt J.C. Glycosylated phosphatidylinositol molecules as second messengers. Semin. Immunol. 1994, 6:97-104.
53. Gonzalez J., Ramalho-Pinto F.J., Frevert U., Ghiso J., Tomlinson S., Scharfstein J., Corey E.J., Nussenzweig V. Proteasome activity is required for the stage-specific transformation of a protozoan parasite. J. Exp. Med. 1996, 184:1909-1918.
54. Grellier P., Blum J., Santana J., Bylen E., Mouray E., Sinou V., Teixeira A.R., Schrevel J. Involvement of calyculin A-sensitive phosphatase(s) in the differentiation of Trypanosoma cruzi trypomastigotes to amastigotes. Mol. Biochem. Parasitol. 1999, 98:239-252.
55. Gutierrez F.R., Guedes P.M., Gazzinelli R.T., Silva J.S. The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol. 2009, 31:673-685.
56. Hall B.F., Webster P., Ma A.K., Joiner K.A., Andrews N.W. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 1992, 176:313-325.
57. Harth G., Andrews N., Mills A.A., Engel J.C., Smith R., McKerrow J.H. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1993, 58:17-24.
58. Hyde T.P., Dvorak J.A. Trypanosoma cruzi: interaction with vertebrate cells in vitro. 2. Quantitative analysis of the penetration phase. Exp. Parasitol. 1973, 34:284-294.
59. Jacobs T., Erdmann H., Fleischer B. Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi. Eur. J. Cell Biol. 2010, 89:113-116.
60. Jou T.S., Nelson W.J. Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity. J. Cell Biol. 1998, 142:85-100.
61. Katzin A.M., Colli W. Lectin receptors in Trypanosoma cruzi. An N-acetyl-d-glucosamine-containing surface glycoprotein specific for the trypomastigote stage. Biochim. Biophys. Acta 1983, 727:403-411.
62. Kayama H., Takeda K. The innate immune response to Trypanosoma cruzi infection. Microbes Infect. 2010, 12:511-517.
63. Kenworthy A.K., Nichols B.J., Remmert C.L., Hendrix G.M., Kumar M., Zimmerberg J., Lippincott-Schwartz J. Dynamics of putative raft-associated proteins at the cell surface. J. Cell Biol. 2004, 165:735-746.
64. Kuhn R.E. Macrophages in experimental Chagas' disease. Immunol. Ser. 1994, 60:495-502.
65. Kulkarni M.M., Olson C.L., Engman D.M., McGwire B.S. Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection. Infect. Immun. 2009, 77:2193-2200.
66. Leite M.F., Moyer M.S., Andrews N.W. Expression of the mammalian calcium signaling response to Trypanosoma cruzi in Xenopus laevis oocytes. Mol. Biochem. Parasitol. 1998, 92:1-13.
67. Luzio J.P., Poupon V., Lindsay M.R., Mullock B.M., Piper R.C., Pryor P.R. Membrane dynamics and the biogenesis of lysosomes. Mol. Membr. Biol. 2003, 20:141-154.
68. Luzio J.P., Bright N.A., Pryor P.R. The role of calcium and other ions in sorting and delivery in the late endocytic pathway. Biochem. Soc. Trans. 2007, 35:1088-1091.
69. Macedo A.M., Machado C.R., Oliveira R.P., Pena S.D. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem. Inst. Oswaldo Cruz 2004, 99:1-12.
70. Maganto-Garcia E., Punzon C., Terhorst C., Fresno M. Rab5 activation by Toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages. Traffic 2008, 9:1299-1315.
71. Manning-Cela R., Cortes A., Gonzalez-Rey E., Van Voorhis W.C., Swindle J., Gonzalez A. LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi. Infect. Immun. 2001, 69:3916-3923.
72. Manning-Cela R., Gonzalez A., Swindle J. Alternative splicing of LYT1 transcripts in Trypanosoma cruzi. Infect. Immun. 2002, 70:4726-4728.
73. Manning-Cela R., Jaishankar S., Swindle J. Life-cycle and growth-phase-dependent regulation of the ubiquitin genes of Trypanosoma cruzi. Arch. Med. Res. 2006, 37:593-601.
74. Manoel-Caetano Fda S., Silva A.E. Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad Saude Publica 2007, 23:2263-2274.
75. Manque P.M., Neira I., Atayde V.D., Cordero E., Ferreira A.T., da Silveira J.F., Ramirez M., Yoshida N. Cell adhesion and Ca2+ signaling activity in stably transfected Trypanosoma cruzi epimastigotes expressing the metacyclic stage-specific surface molecule gp82. Infect. Immun. 2003, 71:1561-1565.
76. Marinho C.R., Bucci D.Z., Dagli M.L., Bastos K.R., Grisotto M.G., Sardinha L.R., Baptista C.R., Goncalves C.P., Lima M.R., Alvarez J.M. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect. Immun. 2004, 72:2350-2357.
77. Mauel J. In vitro induction of intracellular killing of parasitic protozoa by macrophages. Immunobiology 1982, 161:392-400.
78. McCabe R.E., Remington J.S., Araujo F.G. Mechanisms of invasion and replication of the intracellular stage in Trypanosoma cruzi. Infect. Immun. 1984, 46:372-376.
79. McGrath M.E., Eakin A.E., Engel J.C., McKerrow J.H., Craik C.S., Fletterick R.J. The crystal structure of cruzain: a therapeutic target for Chagas' disease. J. Mol. Biol. 1995, 247:251-259.
80. Meirelles M.N., Juliano L., Carmona E., Silva S.G., Costa E.M., Murta A.C., Scharfstein J. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 1992, 52:175-184.
81. Melo R.C., Brener Z. Tissue tropism of different Trypanosoma cruzi strains. J. Parasitol. 1978, 64:475-482.
82. Milei J., Guerri-Guttenberg R.A., Grana D.R., Storino R. Prognostic impact of Chagas disease in the United States. Am. Heart J. 2009, 157:22-29.
83. Ming M., Ewen M.E., Pereira M.E.A. Trypanosome invasion of mammalian cells requires activation of the TGF beta signalling pathway. Cell 1995, 82:287-296.
84. Moncayo A., Silveira A.C. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):17-30.
85. Monteon V.M., Furuzawa-Carballeda J., Alejandre-Aguilar R., Aranda-Fraustro A., Rosales-Encina J.L., Reyes P.A. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model. Exp. Parasitol. 1996, 83:267-274.
86. Moody T.N., Ochieng J., Villalta F. Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3. FEBS Lett. 2000, 470:305-308.
87. Mortara R.A., Procopio D.O., Barros H.C., Verbisck N.V., Andreoli W.K., Silva R.B., da Silva S. Features of host cell invasion by different infective forms of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 1999, 94(Suppl. 1):135-137.
88. Mortara R.A., Andreoli W.K., Taniwaki N.N., Fernandes A.B., Silva C.V., Fernandes M.C., L'Abbate C., Silva S. Mammalian cell invasion and intracellular trafficking by Trypanosoma cruzi infective forms. An. Acad. Bras. Cienc. 2005, 77:77-94.
89. Mortara R.A., Andreoli W.K., Fernandes M.C., da Silva C.V., Fernandes A.B., L'Abbate C., da Silva S. Host cell actin remodeling in response to Trypanosoma cruzi: trypomastigote versus amastigote entry. Subcell. Biochem. 2008, 47:101-109.
90. Mott G.A., Burleigh B.A. The role of host cell lysosomes in Trypanosoma cruzi invasion. Subcell. Biochem. 2008, 47:165-173.
91. Muia R.P., Yu H., Prescher J.A., Hellman U., Chen X., Bertozzi C.R., Campetella O. Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation. Glycobiology. 2010, 20:833-842.
92. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 1992, 22:301-307.
93. Murta A.C., Persechini P.M., Padron T., de Souza W., Guimaraes J.A., Scharfstein J. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol. Biochem. Parasitol. 1990, 43:27-38.
94. Neira I., Ferreira A.T., Yoshida N. Activation of distinct signal transduction pathways in Trypanosoma cruzi isolates with differential capacity to invade host cells. Int. J. Parasitol. 2002, 32:405-414.
95. Neira I., Silva F.A., Cortez M., Yoshida N. Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells. Infect. Immun. 2003, 71:557-561.
96. Ortega-Barria E., Pereira M.E. A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 1991, 67:411-421.
97. Perez-Molina J.A., Perez-Ayala A., Moreno S., Fernandez-Gonzalez M.C., Zamora J., Lopez-Velez R. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J. Antimicrob. Chemother. 2009, 64:1139-1147.
98. Procopio D.O., da Silva S., Cunningham C.C., Mortara R.A. Trypanosoma cruzi: effect of protein kinase inhibitors and cytoskeletal protein organization and expression on host cell invasion by amastigotes and metacyclic trypomastigotes. Exp. Parasitol. 1998, 90:1-13.
99. Ramirez M.I., Ruiz Rde C., Araya J.E., Da Silveira J.F., Yoshida N. Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect. Immun. 1993, 61:3636-3641.
100. Rassi A., Rassi A., Little W.C. Chagas' heart disease. Clin. Cardiol. 2000, 23:883-889.
101. Rassi A., Dias J.C., Marin-Neto J.A., Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart 2009, 95:524-534.
102. Recinos R.F., Kirchhoff L.V., Donelson J.E. Cell cycle expression of histone genes in Trypanosoma cruzi. Mol. Biochem. Parasitol. 2001, 113:215-222.
103. Rodriguez A., Rioult M.G., Ora A., Andrews N.W. A trypanosome-soluble factor induces IP3 formation, intracellular Ca2+ mobilization and microfilament rearrangement in host cells. J. Cell Biol. 1995, 129:1263-1273.
104. Rodriquez A., Samoff E., Rioult M.G., Chung A., Andrews N.W. Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport. J. Cell Biol. 1996, 134:349-362.
105. Romano P.S., Arboit M.A., Vazquez C.L., Colombo M.I. The autophagic pathway is a key component in the lysosomal dependent entry of Trypanosoma cruzi into the host cell. Autophagy 2009, 5:6-18.
106. Ropert C., Ferreira L.R., Campos M.A., Procopio D.O., Travassos L.R., Ferguson M.A., Reis L.F., Teixeira M.M., Almeida I.C., Gazzinelli R.T. Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. 2002, 4:1015-1025.
107. Rubin-de-Celis S.S., Uemura H., Yoshida N., Schenkman S. Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole. Cell. Microbiol. 2006, 8:1888-1898.
108. Ruiz R.C., Favoreto S., Dorta M.L., Oshiro M.E., Ferreira A.T., Manque P.M., Yoshida N. Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity. Biochem. J. 1998, 330:505-511.
109. Santana J.M., Grellier P., Schrevel J., Teixeira A.R. A Trypanosoma cruzi-secreted 80kDa proteinase with specificity for human collagen types I and IV. Biochem. J. 1997, 325(Pt 1):129-137.
110. Sathler-Avelar R., Vitelli-Avelar D.M., Teixeira-Carvalho A., Martins-Filho O.A. Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):246-251.
111. Scharfstein J., Lima A.P. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Subcell. Biochem. 2008, 47:140-154.
112. Scharfstein J., Schmitz V., Morandi V., Capella M.M., Lima A.P., Morrot A., Juliano L., Muller-Esterl W. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 2000, 192:1289-1300.
113. Scharfstein J., Monteiro A.C., Schmitz V., Svensjo E. Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway. Biol. Chem. 2008, 389:1015-1024.
114. Schenkman S., Diaz C., Nussenzweig V. Attachment of Trypanosoma cruzi trypomastigotes to receptors at restricted cell surface domains. Exp. Parasitol. 1991, 72:76-86.
115. Schenkman S., Robbins E.S., Nussenzweig V. Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton. Infect. Immun. 1991, 59:645-654.
116. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 2007, 102(Suppl. 1):75-85.
117. Snary D. Receptors and recognition mechanisms of Trypanosoma cruzi. Trans. Roy. Soc. Trop. Med. Hyg. 1985, 79:587-590.
118. Souto-Padron T., Campetella O.E., Cazzulo J.J., de Souza W. Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. J. Cell Sci. 1990, 96:485-490.
119. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
120. Stoka V., Nycander M., Lenarcic B., Labriola C., Cazzulo J.J., Bjork I., Turk V. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily. FEBS Lett. 1995, 370:101-104.
121. Taki S. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. Cytokine Growth Factor Rev. 2002, 13:379-391.
122. Tanowitz H., Wittner M., Kress Y., Bloom B. Studies of in vitro infection by Trypanosoma cruzi. I. Ultrastructural studies on the invasion of macrophages and L-cells. Am. J. Trop. Med. Hyg. 1975, 24:25-33.
123. Tanowitz H.B., Kaul D.K., Chen B., Morris S.A., Factor S.M., Weiss L.M., Wittner M. Compromised microcirculation in acute murine Trypanosoma cruzi infection. J. Parasitol. 1996, 82:124-130.
124. Tardieux I., Webster P., Ravesloot J., Boron W., Lunn J.A., Heuser J.E., Andrews N.W. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 1992, 71:1117-1130.
125. 2+ transients. J. Exp. Med. 1994, 179:1017-1022.
126. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 2007, 19:430-434.
127. Teixeira S.M. Control of gene expression in Trypanosomatidae. Braz. J. Med. Biol. Res. 1998, 31:1503-1516.
128. Teixeira S.M., daRocha W.D. Control of gene expression and genetic manipulation in the Trypanosomatidae. Genet. Mol. Res. 2003, 2:148-158.
129. Thorne K.J., Blackwell J.M. Cell-mediated killing of protozoa. Adv. Parasitol. 1983, 22:43-151.
130. Tiede A., Bastisch I., Schubert J., Orlean P., Schmidt R.E. Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol. Chem. 1999, 380:503-523.
131. Todorov A.G., Einicker-Lamas M., de Castro S.L., Oliveira M.M., Guilherme A. Activation of host cell phosphatidylinositol 3-kinases by Trypanosoma cruzi infection. J. Biol. Chem. 2000, 275:32182-32186.
132. Todorov A.G., Andrade D., Pesquero J.B., Araujo Rde C., Bader M., Stewart J., Gera L., Muller-Esterl W., Morandi V., Goldenberg R.C., Neto H.C., Scharfstein J. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J. 2003, 17:73-75.
133. Tomlinson S., Vandekerckhove F., Frevert U., Nussenzweig V. The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH. Parasitology 1995, 110:547-554.
134. Tonelli R.R., Silber A.M., Almeida-de-Faria M., Hirata I.Y., Colli W., Alves M.J. l-Proline is essential for the intracellular differentiation of Trypanosoma cruzi. Cell. Microbiol. 2004, 6:733-741.
135. Turner C.W., Lima M.F., Villalta F. Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells. Biochem. Biophys. Res. Commun. 2002, 290:29-34.
136. Tyler K.M., Engman D.M. The life cycle of Trypanosoma cruzi revisited. Int. J. Parasitol. 2001, 31:472-481.
137. Tyler K.M., Luxton G.W., Applewhite D.A., Murphy S.C., Engman D.M. Responsive microtubule dynamics promote cell invasion by Trypanosoma cruzi. Cell. Microbiol. 2005, 7:1579-1591.
138. Vago A.R., Andrade L.O., Leite A.A., d'Avila Reis D., Macedo A.M., Adad S.J., Tostes S., Moreira M.C., Filho G.B., Pena S.D. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 2000, 156:1805-1809.
139. Vieira M., Dutra J.M., Carvalho T.M., Cunha-e-Silva N.L., Souto-Padron T., Souza W. Cellular signaling during the macrophage invasion by Trypanosoma cruzi. Histochem. Cell Biol. 2002, 118:491-500.
140. Villalta F., Kierszenbaum F. Role of cell surface mannose residues in host cell invasion by Trypanosoma cruzi. Biochim. Biophys. Acta 1983, 736:39-44.
141. Villalta F., Kierszenbaum F. Host cell invasion by Trypanosoma cruzi: role of cell surface galactose residues. Biochem. Biophys. Res. Commun. 1984, 119:228-235.
142. Villalta F., Zhang Y., Bibb K.E., Burns J.M., Lima M.F. Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through the MAP kinase pathway. Biochem. Biophys. Res. Commun. 1998, 249:247-252.
143. Villalta F., Zhang Y., Bibb K.E., Pratap S., Burns J.M., Lima M.F. Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through protein kinase C activation. Mol. Cell Biol. Res. Commun. 1999, 2:64-70.
144. Villalta F., Smith C.M., Ruiz-Ruano A., Lima M.F. A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection. FEBS Lett. 2001, 505:383-388.
145. Villalta F., Scharfstein J., Ashton A.W., Tyler K.M., Guan F., Mukherjee S., Lima M.F., Alvarez S., Weiss L.M., Huang H., Machado F.S., Tanowitz H.B. Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol. Res. 2009, 104:1251-1260.
146. Wilkowsky S.E., Barbieri M.A., Stahl P.D., Isola E.L. Regulation of Trypanosoma cruzi invasion of nonphagocytic cells by the endocytically active GTPases dynamin, Rab5, and Rab7. Biochem. Biophys. Res. Commun. 2002, 291:516-521.
147. Williams G.T. Control of differentiation in Trypanosoma cruzi. Curr. Top. Microbiol. Immunol. 1985, 117:1-22.
148. Woolsey A.M., Burleigh B.A. Host cell actin polymerization is required for cellular retention of Trypanosoma cruzi and early association with endosomal/lysosomal compartments. Cell. Microbiol. 2004, 6:829-838.
149. Woolsey A.M., Sunwoo L., Petersen C.A., Brachmann S.M., Cantley L.C., Burleigh B.A. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J. Cell Sci. 2003, 116:3611-3622.
150. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An. Acad. Bras. Cienc. 2006, 78:87-111.
151. Yoshida N., Cortez M. Trypanosoma cruzi: parasite and host cell signaling during the invasion process. Subcell. Biochem. 2008, 47:82-91.
152. Yoshida N., Mortara R.A., Araguth M.F., Gonzalez J.C., Russo M. Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi. Infect. Immun. 1989, 57:1663-1667.
153. Yoshida N., Blanco S.A., Araguth M.F., Russo M., Gonzalez J. The stage-specific 90-kilodalton surface antigen of metacyclic trypomastigotes of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1990, 39:39-46.
154. Yoshida N., Favoreto S., Ferreira A.T., Manque P.M. Signal transduction induced in Trypanosoma cruzi metacyclic trypomastigotes during the invasion of mammalian cells. Braz. J. Med. Biol. Res. 2000, 33:269-278.
155. Zacks M.A., Garg N. Recent developments in the molecular, biochemical and functional characterization of GPI8 and the GPI-anchoring mechanism. Mol. Membr. Biol. 2006, 23:209-225.
156. Zago M.P., Barrio A.B., Cardozo R.M., Duffy T., Schijman A.G., Basombrio M.A. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi. Infect. Immun. 2008, 76:443-451.
157. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 1999, 180:480-486.
158. Zhong L., Lu H.G., Moreno S.N.J., Docampo R. Tyrosine phosphate hydrolysis of host proteins by Trypanosoma cruzi is linked to cell invasion. FEMS Microbiol. Lett. 1998, 161:15-20.